Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru
Eduardo Payet(Instituto Nacional de Enfermedades Neoplásicas), Alexis Holguín(Instituto Nacional de Enfermedades Neoplásicas), Jorge Dunstan(The University of Texas MD Anderson Cancer Center), Ronald Andrade Perez(Instituto Nacional de Enfermedades Neoplásicas), Nanto Caparachín(Instituto Nacional de Enfermedades Neoplásicas), Silvia P. Neciosup(Instituto Nacional de Enfermedades Neoplásicas), J. Pozas Perez(Instituto Nacional de Enfermedades Neoplásicas), Santiago Salgado(Peruvian University of Applied Sciences), Gustavo R. Sarria(University of Bonn), Francisco Berrospi(Instituto Nacional de Enfermedades Neoplásicas), Sheila Vilchez(Instituto Nacional de Enfermedades Neoplásicas), Joseph A. Pinto(Universidad Privada San Juan Bautista), Mauricio Vassallo(Peruvian University of Applied Sciences)
Cited by 0
Related Papers
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
|World Journal of Clinical Oncology|2016|60
Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America
|Clinical & Translational Oncology|2017|58